Chase Sun Achieves Top Ranking in Chinese Herbal Medicine Industry

The "Top 100 Chinese Pharmaceutical Companies" series of rankings, hosted by Menet, a leading health information platform in China, evaluates pharmaceutical companies based on their innovation and professional promotion capabilities. These rankings, supported by Menet's extensive market database, are recognised as one of the most authoritative and closely watched lists in the Chinese pharmaceutical industry, garnering attention from research institutions, industry experts, entrepreneurs, and peers for over a decade.

Chase Sun Pharmaceuticals has once again secured a spot in the "Top 100 Chinese Herbal Medicine Companies" list. This achievement highlights the company's strong innovation drive, professional promotion capabilities, and significant brand influence within the industry. Chase Sun Pharmaceuticals has consistently prioritised scientific research and innovation as its strategic foundation for growth. In recent years, the company has accelerated the development of new productive capacities, reinforcing its competitive edge in core business areas. These areas include traditional Chinese medicine (TCM) formula granules, finished drugs, raw materials, medical devices, healthcare services, and intelligent supply chains for pharmaceuticals and medical devices.

Among its key achievements, Chase Sun Pharmaceuticals' independently developed product, Xuebijing Injection, has garnered widespread attention for its evidence-based medical research, prominently featuring at major academic conferences in critical care and related disciplines. This product has become a significant voice in sepsis treatment in China. Additionally, Chase SunPharmaceuticals' digital TCM formula granule production bases in Tianjin, Chongqing, Beijing, and Henan have been recognised as "smart factories" and "digital workshops."

These accomplishments underscore Chase Sun Pharmaceuticals' solid progress in technological innovation and its commitment to high-quality development and industrial structure optimisation.